Bronchiectasis
exp date isn't null, but text field is
Bronchiectasis is a progressive respiratory disease characterized by permanent dilatation of the bronchi and associated with a clinical syndrome of cough, sputum production and recurrent respiratory infections.
Investigations
FBP, ESR, Serum IgE and IgE to aspergillus, serum immunoglobulin (IgG, IgA, IgM) CXR, Sputum culture and sensitivity, CT-Chest (CT contrast if suspicion of PE/HRCT, bronchoscopy.
Non-pharmacological Treatment
- Physiotherapy and postural drainage
- Avoid smoking
- Airways clearance technique
- Pulmonary rehabilitation
- Respiratory care during childhood measles helps prevent the development of bronchiectasis in children
Pharmacological Treatment
Consider antibiotics in patients with bronchiectasis with >3 exacerbations per year (empirical treatment while wait for culture and sensitivity).
Adults:
A: ciprofloxacin (PO) 500mg 12hourly for 10days
AND
A: metronidazole (PO) 400mg 8hourly for 10days
Children:
A: amoxicillin (PO) 40mg/kg in 2 divided doses for 7days
AND
A: metronidazole (PO) 7.5 mg/kg 8hourly for 5–7days
If Pseudomonas aeruginosa suspicion (should be culture guided)
D: ceftazidime (IV) 2g 8hourly for 14days
OR
S: piperacillin + tazobactam (FDC) (IV) 4.5mg 8hourly for 14days
AND
D: itraconazole (PO) 100mg-200mg 12hourly
Prevention of infection
A: ciprofloxacin 500mg (PO) 24hourly for 7–14days
OR
A: erythromycin (PO) 250–500mg 24hourly for 7–14days